Different expression of transforming growth factor β1 in pancreatic ductal adenocarcinoma and cystic neoplasms

Pancreas

Volumn 15, Issue 1, 1997, Pages 41-47

  Van Laethem, Jean Luc ^a   Resibois, Anne ^b   Rickaert, Fabienne ^a   Devière, Jacques ^a   Gelin, Michel ^a   Cremer, Michel ^a   Robberecht, Patrick ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Intraductal papillary mucinous neoplasm; Pancreatic ductal adenocarcinoma; Serous cystadenoma; Stroma reaction; Transforming growth factor

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOMA; EPITHELIUM CELL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; STROMA CELL;

EID: 0030659033     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199707000-00006     Document Type: Article

References (26)

1. Almoguera C, Shibata D, Forrester K, Martin J, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
2. Lemoine NR, Jain S, Hughes CM, et al. Ki-ras gene oncogene activation in preinvasive pancreatic cancer. Gastroenterologe 1992;102:230-6.
3. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br J Cancer 1991;64:1076-82.
4. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90: 1352-60.
5. Yamanaka Y, Friess H, Büchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289-96.
6. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR. The c-erb-B-2 protooncogene in human pancreatic cancer. J Pathol 1990;161:1995-2000.
7. Lemoine NR, Lobresco M, Leung H, et al. The erb-B-3 gene in human pancreatic cancer. J Pathol 1992;168:269-73.
8. Friess H, Yamanaka Y, Buchler M, et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993; 105:1846-56.
9. Morohoschi T, Kanda M, Asanuma K, Kloppel G. Intraductal papillary neoplasms of the pancreas. Cancer 1984;64:1329-35.
10. Rickaert F, Cremer M, Deviere J, et al. Intraductal mucinhypersecreting neoplasms of the pancreas. Gastroenterology 1991;101:512-9.
11. Tada M, Omata M, Ohio M. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Cancer 1991;67:634-7.
12. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumors represent a distinct group of pancreatic neoplasms: an investigation of tumor cell differentiation and K-ras, p53 and c-erb-B-2 abnormalities in 26 patients. Virchows Arch 1994;425:357-67.
13. 1: purification from human platelets and structural characterization. J Biol Chem 1988;263:6407-15.
14. 1 with multiple repeated sequences. Cell 1990;61:1051-61.
15. Yoshini N, Sugie S, Tanaka T, et al. A rare case of serous cystadenocarcinoma of the pancreas. Cancer 1992;69:2449-53.
16. 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 1993;53:183-90.
17. 1. EMBO J 1991;10:1091-101.
18. 1 associates to fibroblast extracellular matrix via latent TGFβ binding protein. J Cell Biol 1994;124:171-81.
19. Hsu SH, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxydase technique. J Histochem Cytochem 1981;29:577-80.
20. 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995; 108:1873-81.
21. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-5.
22. Moses HL, Yang EY, Pietenpol JA. TGFβ stimulation and inhibition of cell proliferation: new mechanism insights. Cell 1990;63:245-7.
23. Sporn MB, Roberts AB. Transforming growth factor β: recent progress and new challenges. J Cell Biol 1992;119:1017-21.
24. Hirayama D, Fujimori T, Satonaka K, et al. Immunohistochemical study of epidermal growth factor and transforming growth factor β in the penetrating type of early gastric cancer. Hum Pathol 1992;23:681-5.
25. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB. Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol 1992; 23:13-20.
26. 1: histochemical localization with antibodies to different epitopes. J Cell Biol 1989;108:653-60.